84 results on '"Lee, Yena"'
Search Results
2. Synthesis of a dual-emissive pyrene-based fluorescent probe for imaging intracellular viscosity
3. Integrated production and inventory routing planning of oxygen supply chains
4. Optimisation frameworks for integrated planning with allocation of transportation resources for industrial gas supply chains
5. Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
6. Microbiome abnormalities as a possible link between diabetes mellitus and mood disorders: Pathophysiology and implications for treatment
7. Sex differences in ketamine's therapeutic effects for mood disorders: A systematic review
8. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
9. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency
10. Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence
11. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
12. Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects
13. Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence
14. Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series
15. The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE)
16. Cardiosphere-derived cells, with and without a biological scaffold, stimulate myogenesis and recovery of muscle function in mice with volumetric muscle loss
17. The Prevalence of Suicidal Behaviour in Fibromyalgia Patients
18. The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence
19. Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment
20. The impact of overweight/obesity on monetary reward processing: A systematic review
21. A Systematic review of the validity of screening depression through Facebook, Twitter, Instagram, and Snapchat
22. Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence
23. Loneliness-based impaired reward system pathway: Theoretical and clinical analysis and application
24. Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
25. Ecological momentary assessment of depressive symptoms using the mind.me application: Convergence with the Patient Health Questionnaire-9 (PHQ-9)
26. A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions
27. Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder
28. Effects of infliximab on brain neurochemistry of adults with bipolar depression
29. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis
30. Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment
31. The Meaningful Change Threshold as Measured by the 16-Item Quick Inventory of Depressive Symptomatology in Adults with Treatment-Resistant Major Depressive and Bipolar Disorder Receiving Intravenous Ketamine
32. The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research
33. Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin
34. The Effect of Loneliness on Distinct Health Outcomes: A Comprehensive Review and Meta-Analysis
35. Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence
36. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis
37. Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression
38. The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence
39. The utility of smartphone-based, ecological momentary assessment for depressive symptoms
40. Projected increases in suicide in Canada as a consequence of COVID-19
41. Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression
42. What is bipolar disorder? A disease model of dysregulated energy expenditure
43. Using early changes in cold cognition to predict response to vortioxetine in major depressive disorder
44. Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine
45. Effort-based decision-making is affected by overweight/obesity in major depressive disorder
46. Machine learning and big data: Implications for disease modeling and therapeutic discovery in psychiatry
47. Stress, epigenetics and depression: A systematic review
48. Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review
49. Comparison of serum essential trace metals between patients with schizophrenia and healthy controls
50. The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.